Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 10.92
-0.41 (-3.62%)
Feb 13, 2026, 4:00 PM EST
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.09B CNY in the quarter ending September 30, 2025, a decrease of -13.76%. This brings the company's revenue in the last twelve months to 4.74B, down -16.85% year-over-year. In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B with 19.38% growth.
Revenue (ttm)
4.74B
Revenue Growth
-16.85%
P/S Ratio
5.14
Revenue / Employee
1.49M
Employees
3,184
Market Cap
24.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.76B | 934.97M | 19.38% |
| Dec 31, 2023 | 4.82B | 1.00B | 26.24% |
| Jan 1, 2023 | 3.82B | 588.64M | 18.21% |
| Jan 1, 2022 | 3.23B | -417.40M | -11.44% |
| Dec 31, 2020 | 3.65B | 505.98M | 16.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 26.83B |
| Beijing Tiantan Biological Products | 6.42B |
| Asymchem Laboratories (Tianjin) | 6.29B |
| Hualan Biological Engineering | 4.27B |
| Xiamen Amoytop Biotech | 3.70B |
| Anhui Anke Biotechnology (Group) | 2.58B |
| Sinocelltech Group | 1.89B |
| Inner Mongolia Furui Medical Science | 1.47B |